Craig Johnson - Sep 21, 2021 Form 4 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Role
Director
Signature
/s/ Lisa Peraza Attorney-in-fact for Craig A. Johnson
Stock symbol
HRTX
Transactions as of
Sep 21, 2021
Transactions value $
-$3,074
Form type
4
Date filed
9/23/2021, 04:29 PM
Previous filing
Jun 22, 2021
Next filing
Dec 23, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HRTX Common Stock Sale -$3.07K -250 -7.49% $12.30 3.09K Sep 21, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of March 3, 2021. The shares were sold by Mr. Johnson to cover his estimated tax liability associated with the vesting of 750 restricted stock units (RSUs) on September 21, 2021.
F2 The range of sales prices received was $12.15 to $12.40. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.